{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:14:54Z","timestamp":1791216894993,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1007\/s00415-006-0390-x","type":"journal-article","created":{"date-parts":[[2007,4,2]],"date-time":"2007-04-02T14:33:20Z","timestamp":1175524400000},"page":"459-464","source":"Crossref","is-referenced-by-count":233,"title":["Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease"],"prefix":"10.1007","volume":"254","author":[{"given":"Camila Andrade Mendes","family":"Medeiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Felipe","family":"Carvalhedo de Bruin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Ariane","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cec\u00edlia","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"de Lourdes Seabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veralice Meireles","family":"Sales de Bruin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,3]]},"reference":[{"key":"390_CR1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00023210-200115040-00002","volume":"15","author":"Larsen","year":"2001","unstructured":"Larsen JP, Tandberg E (2001) Sleep disorders in patients with Parkinson's disease: epidemiology and management. CNS Drugs 15:267\u2013275","journal-title":"CNS Drugs"},{"key":"390_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/PL00007773","volume":"247","author":"Clarenbach","year":"2000","unstructured":"Clarenbach P (2000) Parkinson's disease and sleep. J. Neurol 247:20\u20132","journal-title":"J. Neurol"},{"key":"390_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.smrv.2005.01.001","volume":"9","author":"Arnulf","year":"2005","unstructured":"Arnulf I (2005) Excessive daytime sleepiness in parkinsonism. Sleep Med 9:185\u2013200","journal-title":"Sleep Med"},{"key":"390_CR4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1034\/j.1600-079X.2002.01885.x","volume":"33","author":"Hebert","year":"2002","unstructured":"Hebert M, Martin SK, Lee C, Eastman CA (2002) The effects of prior light history on the suppression of melatonin by light in humans. J Pineal Res 33:198\u2013203","journal-title":"J Pineal Res"},{"key":"390_CR5","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1152\/japplphysiol.00924.2001","volume":"92","author":"Dijk","year":"2002","unstructured":"Dijk DJ, Lockley SW (2002) Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol 92:852\u2013862","journal-title":"J Appl Physiol"},{"key":"390_CR6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1600-079X.1996.tb00287.x","volume":"21","author":"Cagnacci","year":"1996","unstructured":"Cagnacci A (1996) Melatonin in elation to physiology in adult humans. J Pineal Res 21:200\u2013213","journal-title":"J Pineal Res"},{"key":"390_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.smrv.2004.05.002","volume":"9","author":"Arendt","year":"2005","unstructured":"Arendt J, Skene DJ (2005) Melatonin as a chronobiotic. Sleep Med Rev 9:25\u201339","journal-title":"Sleep Med Rev"},{"key":"390_CR8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.exger.2005.08.009","volume":"40","author":"Pandi-Perumal","year":"2005","unstructured":"Pandi-Perumal SR, Zisapel N, Srinivasan V, Cardinali DP (2005) Melatonin and sleep in aging population. Exp Gerontol 40:911\u2013925","journal-title":"Exp Gerontol"},{"key":"390_CR9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1164\/rccm.200404-488OC","volume":"170","author":"Campos","year":"2004","unstructured":"Campos FL, Silva-J\u00fanior FP, De Bruin VMS, De Bruin PFC (2004) Melatonin Improves Sleep in Asthma. Am J Resp Crit Care 170:947\u2013951","journal-title":"Am J Resp Crit Care"},{"key":"390_CR10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1096\/fj.00-0129com","volume":"15","author":"Dabbeni-Sala","year":"2001","unstructured":"Dabbeni-Sala F, Di Santo S, Franceschini D, Skaper SD, Giusti P (2001) Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J 15:164\u2013170","journal-title":"FASEB J"},{"key":"390_CR11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-079X.2000.290106.x","volume":"29","author":"Absi","year":"2000","unstructured":"Absi E, Ayala A, Machado A, Parrado J (2000) Protective effect of melatonin against the 1-methyl-4-phenylpyridinium-induced inhibition of complex I of the mitochondrial respiratory chain. J Pineal Res 29:40\u201347","journal-title":"J Pineal Res"},{"key":"390_CR12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0031-9384(99)00023-2","volume":"66","author":"Willis","year":"1999","unstructured":"Willis GL, Armstrong SM (1999) A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease. Physiol Behav 66:785\u2013795","journal-title":"Physiol Behav"},{"key":"390_CR13","unstructured":"Rechtshaffen A, Kales A, editors. A Manual Of Standardized Terminology, Techniques And Scoring System For Sleep Stages Of Human Subjects. Los Angeles CA: BIS\/BRI, UCLA; 1968"},{"key":"390_CR14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193\u2013213","journal-title":"Psychiatry Res"},{"key":"390_CR15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"Johns","year":"1991","unstructured":"Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540\u2013545","journal-title":"Sleep"},{"key":"390_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.smrv.2004.06.004","volume":"9","author":"Brzezinski","year":"2005","unstructured":"Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I (2005) Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 9:41\u201350","journal-title":"Sleep Med Rev"},{"key":"390_CR17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/00207459408986015","volume":"77","author":"Vgontzas","year":"1994","unstructured":"Vgontzas AN, Bixler EO, Kales A, Manfredi RL, Tyson K (1994) Validity and clinical utility of sleep laboratory criteria for insomnia. Int J Neurosci 77:11\u201321","journal-title":"Int J Neurosci"},{"key":"390_CR18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","volume":"6","author":"Dowling","year":"2005","unstructured":"Dowling GA, Mastick J, Colling E, Carter JH, Singer CM, Aminoff MJ (2005) Melatonin for sleep disturbances in Parkinson's Disease. Sleep Med 6:459\u2013466","journal-title":"Sleep Med"},{"key":"390_CR19","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","volume":"58","author":"Arnulf","year":"2002","unstructured":"Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y (2002) Parkinson's disease and sleepiness: an integral part of PD. Neurology 58:1019\u20131024","journal-title":"Neurology"},{"key":"390_CR20","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00415-004-0564-3","volume":"251","author":"Happe","year":"2004","unstructured":"Happe S, Anderer P, Pirker W, Klosch G, Gruber G, Saletu B, Zeitlhofer J (2004) Sleep microstructure and neurodegeneration as measured by [123I]beta-CIT SPECT in treated patients with Parkinson's disease. J Neurol 251:1465\u20131471","journal-title":"J Neurol"},{"key":"390_CR21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1468-1331.2004.00971.x","volume":"12","author":"Kaynak","year":"2005","unstructured":"Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O (2005) Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur J Neurol 12:199\u2013207","journal-title":"Eur J Neurol"},{"key":"390_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2004.09.035","volume":"228","author":"Romigi","year":"2005","unstructured":"Romigi A, Brusa L, Marciani MG, Pierantozzi M, Placidi F, Izzi F, Sperli F, Testa F, Stanzione P (2005) Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study. J Neurol Sci 228:7\u201310","journal-title":"J Neurol Sci"},{"key":"390_CR23","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/mds.20624","volume":"20","author":"Diederich","year":"2005","unstructured":"Diederich NJ, Vaillant M, Leischen M, Mancuso G, Golinval S, Nati R, Schlesser M (2005) Sleep apnea syndrome in Parkinson's disease. A casecontrol study in 49 patients. Mov Disord 20:1413\u20131418","journal-title":"Mov Disord"},{"key":"390_CR24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2003.08.010","volume":"217","author":"Monte","year":"2004","unstructured":"Monte FS, da Silva-Junior FP, Braga- Neto P, Nobre e Souza MA, Sales de Bruin VM (2004) Snoring and excessive daytime sleepiness in Parkinson's disease. J Neurol Sci 217:41\u201345","journal-title":"J Neurol Sci"},{"key":"390_CR25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0633.2002.290401.x","volume":"29","author":"Seabra","year":"2000","unstructured":"Seabra ML, Bignotto M, Pinto LR Jr, Tufik S (2000) Randomized, doubleblind clinical trial, controlled with placebo, of the toxicology chronic melatonin treatment. J Pineal Res 29:193\u2013200","journal-title":"J Pineal Res"},{"key":"390_CR26","first-page":"99","volume":"5","author":"Dowling","year":"2003","unstructured":"Dowling GA, Mastick J, Aminoff MJ (2003) Melatonin treatment for insomnia in Parkinson's disease: A pilot Study. Sleep Research Online 5:99\u2013103","journal-title":"Sleep Research Online"},{"key":"390_CR27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00002826-200207000-00002","volume":"25","author":"Bruguerolle","year":"2002","unstructured":"Bruguerolle B, Simon N (2002) Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin Neuropharmacol 25:194\u2013201","journal-title":"Clin Neuropharmacol"},{"key":"390_CR28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00002826-200303000-00005","volume":"26","author":"Bordet","year":"2003","unstructured":"Bordet R, Devos D, Brique S, Touitou Y, Guieu JD, Libersa C, Destee A (2003) Study of circadian melatonin secretion pattern at different stages of Parkinson's disease. Clin Neuropharmacol 26:65\u201372","journal-title":"Clin Neuropharmacol"},{"key":"390_CR29","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/07420520500263334","volume":"22","author":"Camara Magalhaes","year":"2005","unstructured":"Camara Magalhaes S, Vitorino Souza C, Rocha Dias T, Felipe Carvalhedo de Bruin P, Meireles Sales de Bruin V (2005) Lifestyle regularity measured by the social rhythm metric in Parkinson's disease. Chronobiol Int 22:917\u2013924","journal-title":"Chronobiol Int"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0390-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-006-0390-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0390-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:04:13Z","timestamp":1559070253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-006-0390-x"}},"subtitle":["A randomized, double blind, placebo-controlled study"],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1007\/s00415-006-0390-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}